These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Endothelin-1 Treatment Induces an Experimental Cerebral Malaria-Like Syndrome in C57BL/6 Mice Infected with Plasmodium berghei NK65. Martins YC; Freeman BD; Akide Ndunge OB; Weiss LM; Tanowitz HB; Desruisseaux MS Am J Pathol; 2016 Nov; 186(11):2957-2969. PubMed ID: 27640146 [TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles derived from plasmodium-infected red blood cells alleviate cerebral malaria in plasmodium berghei ANKA-infected C57BL/6J mice. Lv Y; Wu S; Nie Q; Liu S; Xu W; Chen G; Du Y; Chen J Int Immunopharmacol; 2024 May; 132():111982. PubMed ID: 38569430 [TBL] [Abstract][Full Text] [Related]
5. Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA. Ding Y; Xu W; Zhou T; Liu T; Zheng H; Fu Y Parasitology; 2016 Oct; 143(12):1672-80. PubMed ID: 27574013 [TBL] [Abstract][Full Text] [Related]
11. S1P is associated with protection in human and experimental cerebral malaria. Finney CA; Hawkes CA; Kain DC; Dhabangi A; Musoke C; Cserti-Gazdewich C; Oravecz T; Liles WC; Kain KC Mol Med; 2011; 17(7-8):717-25. PubMed ID: 21556483 [TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling of the brain of mice with experimental cerebral malaria. Moussa E; Huang H; Ahras M; Lall A; Thezenas ML; Fischer R; Kessler BM; Pain A; Billker O; Casals-Pascual C J Proteomics; 2018 May; 180():61-69. PubMed ID: 28602553 [TBL] [Abstract][Full Text] [Related]
13. Oral Therapy Using a Combination of Nanotized Antimalarials and Immunomodulatory Molecules Reduces Inflammation and Prevents Parasite Induced Pathology in the Brain and Spleen of Mukherjee S; Ray G; Saha B; Kar SK Front Immunol; 2021; 12():819469. PubMed ID: 35095923 [TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria. DellaValle B; Hempel C; Staalsoe T; Johansen FF; Kurtzhals JA Malar J; 2016 Aug; 15(1):427. PubMed ID: 27554094 [TBL] [Abstract][Full Text] [Related]
16. Perivascular Arrest of CD8+ T Cells Is a Signature of Experimental Cerebral Malaria. Shaw TN; Stewart-Hutchinson PJ; Strangward P; Dandamudi DB; Coles JA; Villegas-Mendez A; Gallego-Delgado J; van Rooijen N; Zindy E; Rodriguez A; Brewer JM; Couper KN; Dustin ML PLoS Pathog; 2015; 11(11):e1005210. PubMed ID: 26562533 [TBL] [Abstract][Full Text] [Related]
17. Correlation of increased expression of intercellular adhesion molecule-1, but not high levels of tumor necrosis factor-alpha, with lethality of Plasmodium yoelii 17XL, a rodent model of cerebral malaria. Shear HL; Marino MW; Wanidworanun C; Berman JW; Nagel RL Am J Trop Med Hyg; 1998 Dec; 59(6):852-8. PubMed ID: 9886187 [TBL] [Abstract][Full Text] [Related]
18. Estradiol, but not dehydroepiandrosterone, decreases parasitemia and increases the incidence of cerebral malaria and the mortality in plasmodium berghei ANKA-infected CBA mice. Libonati RM; Cunha MG; Souza JM; Santos MV; Oliveira SG; Daniel-Ribeiro CT; Carvalho LJ; do Nascimento JL Neuroimmunomodulation; 2006; 13(1):28-35. PubMed ID: 16699290 [TBL] [Abstract][Full Text] [Related]
19. P-selectin contributes to severe experimental malaria but is not required for leukocyte adhesion to brain microvasculature. Chang WL; Li J; Sun G; Chen HL; Specian RD; Berney SM; Granger DN; van der Heyde HC Infect Immun; 2003 Apr; 71(4):1911-8. PubMed ID: 12654808 [TBL] [Abstract][Full Text] [Related]
20. Blood-cerebrospinal fluid barrier: another site disrupted during experimental cerebral malaria caused by Plasmodium berghei ANKA. Ngo-Thanh H; Sasaki T; Suzue K; Yokoo H; Isoda K; Kamitani W; Shimokawa C; Hisaeda H; Imai T Int J Parasitol; 2020 Dec; 50(14):1167-1175. PubMed ID: 32882285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]